---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-035398"
form_type: "8-K"
ticker: "AIFF"
cik: "0000803578"
company_name: "FIREFLY NEUROSCIENCE, INC."
filed_at: "2024-11-15T23:59:59+00:00"
generated_at: "2026-05-30T00:04:11.312221+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "medium"
source: SEC EDGAR
---

# Firefly Neuroscience Q3 cash $1.2M; partners with Bright Minds, Novartis, Takeda

## Summary
- Cash $1.2M as of Sept 30, 2024; shares outstanding 8,503,365 as of Nov 12.
- Partnered with Bright Minds, Novartis, Takeda for BNA platform in drug development.
- Integrated BNA technology at Neurology Consultants of Dallas; partnered with Zeto for EEG devices.
- Appointed Dr. Stella Vnook to Board of Directors.
- Completed merger with WaveDancer; listed on Nasdaq under ticker AIFF.

## SEC filing metadata
- accession: 0001437749-24-035398
- form_type: 8-K
- ticker: AIFF
- cik: 0000803578
- company_name: FIREFLY NEUROSCIENCE, INC.
- filed_at: 2024-11-15T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: medium
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/803578/000143774924035398/0001437749-24-035398-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/803578/000143774924035398/wavd20241112_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-035398
- JSON: https://secwatch.observer/filing/0001437749-24-035398.json
- Plain text: https://secwatch.observer/filing/0001437749-24-035398.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.